Studies have indicated that 30%-80% of cancer patients use complementary and alternative practices and products (CAPPs), but little is known about CAPPs use by persons with brain tumors. This secondary analysis of Glioma Outcomes Project data compared CAPPs users with nonusers, compared those who stopped using CAPPs with those who continued use, described frequency and patterns of CAPPs use, and compared the relationship of CAPPs use to self-reported quality of life (QOL) over time, in 186 persons with high-grade gliomas. CAPPs users at all three measurement points rated QOL higher, although not significantly higher, than nonusers. Study findings support further exploration of CAPPs use and its effects on key outcomes in persons with high-grade gliomas.
Questions or comments about this article may be directed to Sherry Fox, PhD RN CNRN, at email@example.com. She is an assistant professor of nursing and Theresa Thomas Fellow at the University of Virginia School of Nursing, Charlottesville, VA.
Edward R. Laws Jr., MD FACS, is a professor of neurosurgery, clinical internal medicine, and pediatrics in the department of neurosurgery at the University of Virginia School of Medicine, Charlottesville, VA.
Frederick Anderson Jr., PhD, is a director of the Center for Outcomes Research at the University of Massachusetts Medical School, Worchester, MA.
Elana Farace, PhD, is an associate professor of neurosurgery at Pennsylvania State University, Hershey, PA.
© 2006 American Association of Neuroscience Nurses